Nystapol (Nystatin)

Nystatin, the active ingredient in Nystapol, is a polyol polyfungal polyphenol presented as a topical formulation for dermal use. It treats superficial fungal infections such as candidiasis in infants, children, and adults. GNH USA supplies Nystapol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and pharmacies worldwide.

GNH USA supplies Nystapol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Nystapol is an antifungal agent that acts on yeast and mould infections of the skin and mucous membranes.

- Oral thrush: Reduces fungal load and promotes healing of oral candidiasis. - Diaper rash: Controls Candida overgrowth associated with irritant diaper dermatitis. - Intertriginous candidiasis: Relieves itching and erythema in skin folds. - Vaginal candidiasis: Alleviates discharge and discomfort caused by Candida species. - Cutaneous candidiasis: Treats localized skin infections caused by Candida. - Esophageal ​  ​  ​  ​  ​  ​ ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​  ​ ​  ​ ​

Nystapol may generate local or systemic reactions, most of which are mild and reversible.

Common Side Effects: - Itching  ​  ​  ​  ​  ​  ​ ​  ​  ...    …  "); -     ...  …  ...  ....  … ");  -  …  ...  "  "  "  "  "  "  "  "  "  "  "  "  -  ");  - "  "  "  "  - "  Serious  " "  "); - "  - "  - "  - "  - "  - "  - "  - "  - "  - "  - "  - …  - … - … - "); -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  -  - "); -  -  -  -  -  -  -  - ");

Nystapol  ");     "  ... 

   " " " " ");   -   t   g   ewline   ewline

t

   t  "  i  g  t \